Side Effects

Wegovy Side Effects in Women: What to Expect

GLP-1 Companion · 8 min read

Wegovy (semaglutide 2.4 mg) is the highest-dose injectable semaglutide approved specifically for chronic weight management. While its core side effects — nausea, constipation, vomiting, and diarrhea — affect both men and women, several specific experiences are unique to or more pronounced in female patients. Understanding these can help women on Wegovy know what is normal, what to monitor, and when to call their doctor.

Common Wegovy Side Effects in Women

The most frequent side effects of Wegovy reported in clinical trials are gastrointestinal and affect women and men at similar rates:

• Nausea (44% of patients in the STEP trials)
• Diarrhea (~30%)
• Vomiting (~24%)
• Constipation (~24%)
• Abdominal pain (~20%)
• Heartburn and acid reflux (~13%)
• Fatigue (~11%)
• Headache (~14%)

Most of these peak during the dose escalation phase (the first 4-5 months when the dose is increased stepwise from 0.25 mg to 2.4 mg) and diminish significantly once a stable dose is reached.

Wegovy and Menstrual Cycle Changes

One of the most commonly reported female-specific experiences on Wegovy is changes to the menstrual cycle. These are not officially listed as a side effect by the FDA, but large numbers of women on Wegovy (and other GLP-1 drugs) have reported:

• Heavier or more intense periods, particularly in the first few months
• Irregular cycle timing — periods arriving earlier or later than expected
• Return of periods in women who had irregular cycles due to obesity-related hormonal disruption
• Changes in PMS symptoms, either improved or temporarily worsened
• Spotting between periods, especially during rapid weight loss phases

The mechanism behind these changes is primarily indirect. As body fat decreases, estrogen levels change — since adipose (fat) tissue is itself a source of estrogen production. Rapid weight loss also affects the hypothalamic-pituitary-ovarian axis, which regulates the menstrual cycle. These changes are generally temporary and cycles tend to normalize as weight stabilizes.

Wegovy and Fertility: An Important Warning

Women who were previously struggling to conceive due to conditions like polycystic ovary syndrome (PCOS) or obesity-related anovulation (lack of ovulation) may find their fertility significantly improves on Wegovy. As weight decreases and hormonal balance is restored, regular ovulation can return — sometimes unexpectedly.

There have been numerous reports of unplanned pregnancies in women on GLP-1 medications who did not expect to ovulate regularly. Hormonal contraceptives (the pill, patch, ring, IUD with hormones, implant) may be less effective if taken orally alongside Wegovy during active vomiting or if gut absorption is altered. IUDs, implants, or other non-oral methods are more reliable contraception options for women on Wegovy.

Wegovy and PCOS

For women with polycystic ovary syndrome, Wegovy can have genuinely beneficial effects:

• Weight loss reduces insulin resistance, which is central to PCOS pathophysiology
• Lower androgen levels as weight decreases can reduce symptoms like facial hair and acne
• Restored ovulation and more regular menstrual cycles
• Improved metabolic markers including blood sugar and cholesterol

Women with PCOS using Wegovy should be aware that these hormonal improvements may restore fertility. Contraception planning is important if pregnancy is not desired.

Hair Loss on Wegovy

Telogen effluvium — temporary hair shedding — is more commonly reported by women on Wegovy than men, likely because women pay more attention to hair volume and may also be more physiologically sensitive to nutritional changes. This type of hair loss is a response to the physical stress of rapid weight loss and reduced caloric intake, not a direct toxicity of semaglutide.

Hair typically starts shedding 2-4 months after the stressful event (in this case, beginning significant weight loss) and lasts 3-6 months before regrowth begins. Steps that may help include:

• Ensuring adequate protein intake (at least 60-80g daily on Wegovy, ideally higher)
• Taking a multivitamin that includes biotin, zinc, and iron
• Getting iron and ferritin levels checked — many women are marginally iron-deficient
• Using gentle hair care products and avoiding heat styling during the shedding phase

Wegovy and Breast Changes

As body fat redistributes during weight loss on Wegovy, many women notice changes in breast size and shape. The breasts contain a significant amount of adipose tissue, so weight loss commonly reduces breast size. This is a natural consequence of fat loss, not a specific drug effect. Some women also notice changes in bra fit or breast firmness as composition changes.

Bone Health Considerations for Women on Wegovy

Rapid weight loss on GLP-1 medications can result in some loss of bone mineral density, particularly at the hip. This is a concern for all patients but especially for women over 45, those approaching menopause, and those with a family history of osteoporosis. The combination of weight loss-related bone changes and declining estrogen around perimenopause requires monitoring.

Women on Wegovy, particularly those over 40, should:

• Ensure adequate calcium intake (1,000-1,200 mg daily from food and supplements combined)
• Maintain vitamin D levels (ask your doctor to check serum 25-OH vitamin D)
• Include resistance training in their exercise routine, which helps preserve bone density
• Discuss a baseline DEXA scan with their doctor if they have risk factors for osteoporosis

Menopausal and Perimenopausal Women on Wegovy

Women in perimenopause or menopause may have a different experience with Wegovy. Weight gain is common during this life stage due to hormonal shifts and metabolic slowing, and Wegovy can be highly effective. However, the already-occurring hormonal changes can make it harder to separate Wegovy side effects from menopause symptoms. Hot flashes, mood changes, sleep disruption, and joint pain can overlap.

The good news: weight loss through Wegovy has been associated with reduced hot flash frequency and severity in some women, and improving metabolic health through weight loss is particularly beneficial during the menopause transition.

Mood Changes and Emotional Side Effects in Women

Some women report emotional changes on Wegovy — both positive and negative. On the positive side, many report reduced anxiety, improved mood, and a sense of control that comes with successful weight loss. On the negative side, a subset reports emotional blunting, low mood, or increased anxiety, particularly in the early months.

Women who have a history of depression, anxiety, or disordered eating should be especially attentive to their mental health while starting Wegovy, and should maintain close communication with their prescriber and mental health team.

When to Contact Your Doctor

Reach out to your healthcare provider if you experience:

• Irregular periods that do not stabilize after 3-4 months on a stable Wegovy dose
• A positive pregnancy test while on Wegovy (stop Wegovy immediately and contact your OB)
• Significant hair loss that does not improve after 6 months
• Severe or worsening mood changes, depression, or anxiety
• Any unusual breast changes beyond expected size reduction
• Signs of hypoglycemia (shakiness, sweating, rapid heart rate, confusion)

The Bottom Line

Wegovy is highly effective for weight management in women and for many, the benefits significantly outweigh the side effects. Women-specific considerations — particularly around menstrual changes, fertility, bone health, and hair — are worth discussing with your doctor before and during treatment. Being prepared for what to expect makes the journey smoother and helps you distinguish what is normal from what needs attention.